{ "cik": 1100682, "cik_padded": "0001100682", "entityName": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.", "fiscal_years": [ { "accn": "0001100682-26-000022", "filed": "2026-02-18", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 360673000.0, "capex": 219152000.0, "cash": 213770000.0, "eps_diluted": -2.91, "free_cash_flow": 518494000.0, "net_income": -144338000.0, "operating_cash_flow": 737646000.0, "operating_income": 25162000.0, "revenue": 4015382000.0, "stockholders_equity": 3164630000.0, "total_assets": 7135422000.0, "total_liabilities": 3924228000.0 }, "period_end": "2025-12-27", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2400274281669579, "net_margin": -0.035946268624006385, "operating_margin": 0.006266402548997829, "revenue_growth_yoy": -0.008544961480142292, "roa_avg2y": -0.019686346625665832, "roa_period_end": -0.020228376121272155, "roe_avg2y": -0.043566285192283345, "roe_period_end": -0.04560975532684706 } }, { "accn": "0001100682-26-000022", "filed": "2026-02-18", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 119175000.0, "capex": 232967000.0, "cash": 194606000.0, "eps_diluted": 0.2, "free_cash_flow": 501610000.0, "net_income": 22203000.0, "operating_cash_flow": 734577000.0, "operating_income": 227347000.0, "revenue": 4049989000.0, "stockholders_equity": 3461503000.0, "total_assets": 7528345000.0, "total_liabilities": 4020267000.0 }, "period_end": "2024-12-28", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1614223647935593, "net_margin": 0.005482237112248946, "operating_margin": 0.05613521419440892, "revenue_growth_yoy": -0.01923277640940871, "roa_avg2y": 0.002824208027985901, "roa_period_end": 0.0029492537868548796, "roe_avg2y": 0.006291240843337392, "roe_period_end": 0.006414265710588724 } }, { "accn": "0001100682-26-000022", "filed": "2026-02-18", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 24155000.0, "capex": 318528000.0, "cash": 276771000.0, "eps_diluted": 9.22, "free_cash_flow": 365370000.0, "net_income": 474624000.0, "operating_cash_flow": 683898000.0, "operating_income": 617261000.0, "revenue": 4129409000.0, "stockholders_equity": 3596882000.0, "total_assets": 8195001000.0, "total_liabilities": 4536003000.0 }, "period_end": "2023-12-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2610930800621205, "net_margin": 0.11493751284990177, "operating_margin": 0.14947925962286612, "revenue_growth_yoy": 0.03856807995855193, "roa_avg2y": 0.060087464237834565, "roa_period_end": 0.057916283353717714, "roe_avg2y": 0.1444124034427807, "roe_period_end": 0.1319542870741937 } }, { "accn": "0001100682-25-000011", "filed": "2025-02-19", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 38651000.0, "capex": 324733000.0, "cash": 233912000.0, "eps_diluted": 9.48, "free_cash_flow": 294907000.0, "net_income": 486226000.0, "operating_cash_flow": 619640000.0, "operating_income": 650975000.0, "revenue": 3976060000.0, "stockholders_equity": 2976293000.0, "total_assets": 7602770000.0, "total_liabilities": 4579265000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5385800389948168, "net_margin": 0.1222883960503614, "operating_margin": 0.1637236359612279, "revenue_growth_yoy": 0.12313002802133237, "roa_avg2y": 0.06648307089967896, "roa_period_end": 0.06395379578758795, "roe_avg2y": 0.17645292339315125, "roe_period_end": 0.1633663083574097 } }, { "accn": "0001100682-24-000007", "filed": "2024-02-14", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 40707000.0, "capex": 228772000.0, "cash": 241214000.0, "eps_diluted": 7.6, "free_cash_flow": 532027000.0, "net_income": 390982000.0, "operating_cash_flow": 760799000.0, "operating_income": 589862000.0, "revenue": 3540160000.0, "stockholders_equity": 2534820000.0, "total_assets": 7024292000.0, "total_liabilities": 4432300000.0 }, "period_end": "2021-12-25", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.748565973126297, "net_margin": 0.11044190093103139, "operating_margin": 0.16662015276145714, "revenue_growth_yoy": 0.21075277716691868, "roa_avg2y": 0.06248152734895215, "roa_period_end": 0.05566141043111533, "roe_avg2y": 0.1681852066773031, "roe_period_end": 0.15424448284296322 } }, { "accn": "0001100682-23-000006", "filed": "2023-02-22", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 23979000.0, "capex": 166560000.0, "cash": 228424000.0, "eps_diluted": 7.2, "free_cash_flow": 380015000.0, "net_income": 364304000.0, "operating_cash_flow": 546575000.0, "operating_income": 432729000.0, "revenue": 2923933000.0, "stockholders_equity": 2114602000.0, "total_assets": 5490831000.0, "total_liabilities": 3347163000.0 }, "period_end": "2020-12-26", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.582880844716878, "net_margin": 0.12459382619232383, "operating_margin": 0.1479955252052629, "revenue_growth_yoy": 0.11548298391668631, "roa_avg2y": 0.07154704598688423, "roa_period_end": 0.0663476985541897, "roe_avg2y": 0.1943376508927538, "roe_period_end": 0.17228017376319513 } }, { "accn": "0001100682-22-000007", "filed": "2022-02-16", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 18087000.0, "capex": 140514000.0, "cash": 238014000.0, "eps_diluted": 5.07, "free_cash_flow": 340422000.0, "net_income": 252019000.0, "operating_cash_flow": 480936000.0, "operating_income": 351151000.0, "revenue": 2621226000.0, "stockholders_equity": 1634584000.0, "total_assets": 4692790000.0, "total_liabilities": 3026315000.0 }, "period_end": "2019-12-28", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.8514282533048163, "net_margin": 0.09614546780781205, "operating_margin": 0.13396441207282395, "revenue_growth_yoy": 0.15671445516871307, "roa_avg2y": 0.058960991471303896, "roa_period_end": 0.05370344720304979, "roe_avg2y": 0.17074943866966405, "roe_period_end": 0.15417928965412606 } }, { "accn": "0001100682-21-000005", "filed": "2021-02-17", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 13846000.0, "capex": 140054000.0, "cash": 195442000.0, "eps_diluted": 4.62, "free_cash_flow": 301086000.0, "net_income": 226373000.0, "operating_cash_flow": 441140000.0, "operating_income": 331383000.0, "revenue": 2266096000.0, "stockholders_equity": 1317332000.0, "total_assets": 3855879000.0, "total_liabilities": 2517576000.0 }, "period_end": "2018-12-29", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.9111173189446549, "net_margin": 0.09989559136064845, "operating_margin": 0.14623519921486117, "revenue_growth_yoy": 0.21990459738124601, "roa_avg2y": 0.06671961055150306, "roa_period_end": 0.05870853312565047, "roe_avg2y": 0.19164565706574468, "roe_period_end": 0.17184202615589692 } }, { "accn": "0001100682-20-000005", "filed": "2020-02-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 106909000.0, "capex": 82431000.0, "cash": 163794000.0, "eps_diluted": 2.54, "free_cash_flow": 235643000.0, "net_income": 123355000.0, "operating_cash_flow": 318074000.0, "operating_income": 288282000.0, "revenue": 1857601000.0, "stockholders_equity": 1045080000.0, "total_assets": 2929922000.0, "total_liabilities": 1865906000.0 }, "period_end": "2017-12-30", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7854192980441688, "net_margin": 0.06640554134068619, "operating_margin": 0.15519048493190948, "revenue_growth_yoy": 0.10477319332568906, "roa_avg2y": 0.04372955633049626, "roa_period_end": 0.0421018033927183, "roe_avg2y": 0.13109985503611343, "roe_period_end": 0.11803402610326483 } }, { "accn": "0001100682-19-000004", "filed": "2019-02-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 12267000.0, "capex": 55288000.0, "cash": 117626000.0, "eps_diluted": 3.23, "free_cash_flow": 261611000.0, "net_income": 154765000.0, "operating_cash_flow": 316899000.0, "operating_income": 237552000.0, "revenue": 1681432000.0, "stockholders_equity": 836768000.0, "total_assets": 2711800000.0, "total_liabilities": 1858016000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.2204673218861144, "net_margin": 0.09204356762569049, "operating_margin": 0.14127957598047378, "roa_period_end": 0.05707094918504314, "roe_period_end": 0.1849556866419366 } } ], "latest_filing": { "accn": "0001100682-26-000022", "filed": "2026-02-18", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "8731", "sic_description": "Services-Commercial Physical & Biological Research", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001100682.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001100682.json" }, "ticker": "CRL" }